Marie Hoäg, MBA
More than two decades of clinical experience, female hormone and HRT education and research — devoted to advancing the clinical standard for female hormone medicine.
Female Hormone Medicine
Can—and Must—Do Better.
I have worked in female hormone medicine for over 20 years and watched thousands of intelligent, capable women become depressed and anxious — they lose energy, cognitive clarity, emotional stability, physical shape, sexual vitality, and their sense of themselves as their hormones decline. Standard-of-care medicine normalizes this as aging, minimizes it as a collection of unrelated complaints, and addresses it with low-dose HRT that never fully restores a woman's depleted hormone tank.
What became clear to me was that women weren't the problem — it was that the prevailing clinical approach was failing to provide women with enough of the right hormones and a clinical plan to a destination of true hormonal balance. Being prescribed low-dose HRT is considered sufficient by conventional medicine standards, even when a woman remains clinically deficient and symptomatic.
Panacea Sciences grew from the conviction that women require a higher standard of hormone care — and deserve more than short-lived symptom management. They deserve hormone therapy that fully replenishes deficient hormones, restores balance, maintains it, and protects the life they have worked so hard to build.
“Women deserve a higher standard of hormone balancing care.”
THE DEVELOPMENT OF A HIGHER STANDARD
Female Hormone Medicine From Every Vantage Point
My perspective on female hormone medicine was not formed through one credential, one patient, one protocol, or one professional role. It developed through several distinct experiences that continually informed, challenged, and validated one another.
I studied through leading hormone, anti-aging, functional, and integrative medicine institutions; worked directly with female patients taking HRT; collaborated intensively with physicians on patient care and clinical findings; researched medical literature in female hormone medicine; and experienced all forms of HRT as a patient myself.
Together, those vantage points gave me an unusually complete understanding of how female hormone therapy is taught, prescribed, applied, experienced, monitored, and adjusted—and why so many women remain hormonally deficient and symptomatic despite receiving hormone treatment.
01 — Advanced Education & Independent Research
My clinical foundation began with extensive professional education through fellowship courses, medical conferences, HRT specialty programs, and leading institutions in hormone, anti-aging, functional, integrative, nutritional, and lifestyle medicine.
I did not rely solely on conference teaching or prevailing medical opinion due to a lack of consensus on care. I independently searched the National Library of Medicine to determine whether published research supported what we were witnessing clinically. I continually compared medical education, emerging evidence, laboratory findings, clinical indicators, and patient outcomes rather than accepting any one source as sufficient on its own.
02 — Directed Patient Care & Clinical Hormone Coaching
As a Clinical Hormone Coach for over two decades, I still maintain a patient schedule inside Panacea Sciences Advanced Hormone Balancing Clinic. I work directly with women, guiding them through the structured process required to reach and maintain the Hormone Sweet Spot™.
Monitoring clinical data on female patients taking all generations of HRT over time revealed what very few get to witness. I saw that not all HRT is the same or yields the same clinical results. I saw how various HRT protocols affected cognition, mood, sleep, energy, weight, sexuality, physical function, and quality of life—and where dose, route, timing, administration, or follow-up needed to change when a woman was symptomatic.
I have also seen first-hand what true hormonal balance looks like. I have seen the minds and bodies of women transform right before me as they were finally getting enough of the right hormones.
03 — Physician Collaboration & Clinical Discovery
My clinical development was, and still is, profoundly shaped through daily collaboration with the hormone physicians. It started over 20 years ago when a physician mentor gave me an extraordinary opportunity to build his hormone practice, invested extensively in my education and training, and included me in the intellectual and clinical work of patient care.
We reviewed cases, discussing HRT protocols, analyzed laboratory findings and clinical indicator data, discussed treatment response, and evaluated the adjustments required to help women achieve better outcomes. I worked with additional physicians and participated in clinical roundtables that exposed me to different prescribing approaches, professional perspectives, patient populations, and clinical outcomes.
The work was strengthened through mentorship, rigorous discussion, disagreement, shared inquiry, and the cumulative experience of caring for thousands of women.
04 — Lived Experience of Hormone Therapy
While developing professionally, I was also undergoing the hormone-balancing process as a patient. I have personally experienced all HRT approaches, including advanced HRT protocols — and learned firsthand how profoundly the approach, dose, route, timing, rhythm, monitoring, and treatment adjustment impact a patient’s result.
That experience did not replace clinical evidence; it added another dimension to it. I understood what hormone deficiency and treatment felt like from inside the patient experience — while simultaneously evaluating the same process through education, laboratory findings, clinical indicators, and direct patient care.
It allowed me to recognize the difference between receiving hormone therapy, experiencing partial improvement, and becoming truly hormonally balanced. This experience also helps me to be a better HRT coach as I walk women through the hormone balancing process to the Hormone Sweet Spot™.
Few people have examined female hormone medicine simultaneously through advanced education, direct patient care, intensive physician collaboration, independent research, and lived experience as a hormone-therapy patient. That convergence became the foundation for the clinical systems I developed through Panacea Sciences.
The synthesis and vision became mine to lead, but the work is strengthened by the physicians who educate me, trust me, challenge me, and collaborate with me along the way. I'll be forever grateful.
THE CLINICAL FAILURES I COULD NOT IGNORE
The Problem Was Never Just One Thing.
The same limitations continue to appear across HRT prescribing, treatment application, patient evaluation, and long-term outcomes. Women could receive hormone therapy, follow instructions, and still remain hormonally out of balance because the prevailing model is not designed around full hormonal restoration.
The problem is not one hormone, one physician, one adjustment, or one laboratory value. It is a collection of clinical assumptions that repeatedly lower the standard of success.
1. The Goal of Treatment Was Too Limited
Symptom Management Instead of Hormonal Restoration The consequences of hormone deficiency were often managed individually rather than recognizing and treating the underlying depletion. Women could receive multiple diagnoses and treatments while the central hormonal cause remained inadequately addressed.
Partial Improvement Accepted as Clinical Success A reduction in a few complaints is frequently considered a successful result, even when a woman remained on HRT, continued to function below her previous capacity, and was nowhere near true hormonal balance.
2. HRT is Prescribed Without Sufficient Application
Routine Reliance on Low-Dose Treatment Low-dose HRT is commonly treated as the safest or most appropriate starting and ending point without adequately accounting for the woman’s degree of depletion, laboratory findings, clinical indicators, or response to treatment.
Inadequate Application Training for Prescribers Knowing which hormones are depleted and which HRT is available is not the same as knowing how to restore them. Advanced results require the ability to apply dose, route, timing, rhythm, administration, monitoring, and adjustment as an integrated clinical process.
Failure to Combine Laboratory Findings With Clinical IndicatorsLaboratory values were often evaluated without a structured measure of how the patient was mentally and physically responding. In other cases, patient complaints were considered without sufficient laboratory assessment. Neither tool is adequate alone.
3. Hormone Deficiency is Treated as Fragmented & Uniform
Fragmented Treatment of Estrogen-Deficiency Consequences Depression, anxiety, mood instability, cognitive decline, brain fog, insomnia, headaches, weight gain, joint pain, sexual dysfunction, and other consequences of hypoestrogenism were frequently treated as unrelated conditions rather than connected manifestations of hormone deficiency.
Failure to Distinguish Clinical Stages and Degrees of Depletion Early, mid, and late stages of perimenopause, menopause, and postmenopause were often collapsed into one generalized category. Yet women at different stages of decline did not have the same clinical picture, the same degree of symptoms, or require the same treatment application.
Together, these failures explain why a woman could be prescribed HRT and remain symptomatic and never become hormonally balanced. They also made clear that improving outcomes would require more than a minor adjustment.
It would require a defined clinical destination, an advanced standard for reaching it, better female HRT application training for prescribers, structured patient HRT coaching, and a proven system for maintaining hormonal balance.
Panacea Sciences was built to solve the full clinical spectrum—not one isolated weakness in female HRT care.
WHAT I BUILT IN RESPONSE
From Clinical Failures to an Integrated Standard
I was not willing to simply document why women continued to suffer on hormone therapy. I was determined to solve it. That required the courage to question accepted clinical assumptions, the discipline to follow patterns others overlooked, and the confidence to keep advancing ideas that challenged the prevailing standard of care.
Over the course of my career, I transformed those observations into an integrated body of work: a defined clinical destination, an advanced application standard, a comprehensive patient-care model, and professional training designed to change what women and clinicians could expect from female hormone medicine.
These solutions were not created quickly or safely from the sidelines. They were built through years of direct clinical application, relentless study, innovation, risk, and an unwavering refusal to accept preventable suffering as inevitable.
"I did not spend my career learning how to work within the limitations of conventional female hormone medicine. I spent it developing the solutions required to move well beyond them."
That work ultimately became four interconnected solutions—each created to address a different part of the clinical problem and, together, establish a more complete and higher standard of female hormone care.
The Hormone Sweet Spot™
A defined clinical destination where blood serum laboratory findings, clinical indicators, and a woman’s lived experience align—this is where true hormonal balance is achieved and maintained.
The Panacea Protocol™
The clinical framework behind everything taught at Panacea Sciences Institute. It's a defined standard for assessing hormone decline, identifying deficiencies, restoring hormones, and achieving sustainable hormonal balance.
The Hormone Sweet Spot™ Program
A physician-directed HRT program that provides the structured roadmap, coordinated clinical team, ongoing monitoring, education, and treatment adjustments required to reach and maintain the Hormone Sweet Spot™.
Panacea Sciences Institute
">Advanced female hormone replacement therapy application training and Panacea Protocol™ training for prescribers — and clinical hormone coach training for non-prescribing healthcare professionals and health coaches.
Together, these four solutions became the clinical architecture of Panacea Sciences—and the foundation for putting a higher standard of female hormone care into practice.
From Clinical Standard to Clinical Practice
I Built a Clinic to Put the Higher Standard Into Practice.
Developing a better clinical standard was not enough. Women also needed a practice specifically designed to apply it—one that moves beyond fragmented low-dose HRT symptom management — and provide therapeutic-dose HRT and a strategic clinical process to reach and maintain true hormonal balance.
I founded Panacea Sciences Advanced Hormone Balancing Clinic, a physician-directed telehealth practice where the Panacea Protocol™ is applied through the Hormone Sweet Spot™ Program. The clinic brings together advanced HRT prescribing, clinical hormone coaching, and long-term hormonal balance within one structured model of care.
Telehealth allows women to access advanced female hormone-balancing care beyond the limitations of conventional low-dose symptom management. Through a coordinated physician-and-coach clinical team, each woman is guided through a defined roadmap to the Hormone Sweet Spot™ rather than being left to navigate ineffective hormone therapy through untrained practitioners and vague care. True Hormonal balance is a clinical destination that we help women achieve and maintain.
THE WORK AHEAD
Building a Clinical Network for Advanced Female Hormone Medicine
Panacea Sciences Advanced Hormone Balancing Clinic demonstrates what becomes possible when advanced HRT prescribing, clinical hormone coaching, a structured process, and a defined clinical destination operate as one coordinated standard of care.
The next phase of this work is to train more prescribers and more Clinical Hormone Coaches in that same higher standard — continuing to grow our network of like-trained professionals who can work together to help women reach and maintain true hormonal balance: the Hormone Sweet Spot™.
The goal is to continue to build the coordinated clinical workforce required to make a higher standard of female hormone care more widely available.
